EIF2A and Alzheimer disease: To test this hypothesis, we compared the abilities of BACE1+/− reduction to affect phosphorylation of the translation initiation factor eIF2α, one of the proposed mediators of BACE1 elevation associated with AD [32], [33], in 5XFAD mice at two different ages (Fig. 5).